AI assistant
Evotec SE — Share Issue/Capital Change 2013
Aug 31, 2013
151_rns_2013-08-31_469ef6e5-b66b-4bef-a2ad-150a279ab226.html
Share Issue/Capital Change
Open in viewerOpens in your device viewer
News Details
Ad-hoc | 31 August 2013 00:33
Evotec raises EUR 30 m from Biotechnology Value Fund
Evotec AG / Key word(s): Capital Increase
31.08.2013 00:33
Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Hamburg, Germany - Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN:
DE0005664809) today announced a capital increase against cash contribution
by issuing 11,818,613 new shares to Biotechnology Value Fund, L.P. and
other affiliates of the US biotech specialist investment firm, BVF Partners
L.P. ('BVF'), San Francisco. Shareholders' subscription rights will be
excluded.
The price is EUR 2.55 per share. This involves a discount of approximately
3% to the closing auction price of the share on 27 August 2013, the day
prior to the day of the Management Board resolution. With the registration
of the capital increase in the commercial register, the registered share
capital of the Company will increase by nearly 10% to EUR 130,365,452.00.
In a simultaneous transaction, BVF also purchased an option from TVM
Capital Life Science ('TVM') granting BVF the right to acquire an
additional 11,818,612 shares of Evotec at EUR 4.00 per share within the
next 30 months. Should this option be exercised in full, BVF will have a
total shareholding in Evotec of over 18%.
Revenue guidance of the Company remains unchanged. Given the capital
inflow, Evotec increases its cash guidance to >EUR 90 m by the end of 2013.
Contact: Dr Werner Lanthaler, Chief Executive Officer, Evotec AG, Manfred
Eigen Campus, Essener Bogen 7, 22419 Hamburg, Germany, Phone: +49.(0)40.560
81-242, [email protected]
31.08.2013 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
Language: English
Company: Evotec AG
Manfred Eigen Campus / Essener Bogen 7
22419 Hamburg
Germany
Phone: +49 (0)40 560 81-0
Fax: +49 (0)40 560 81-222
E-mail: [email protected]
Internet: www.evotec.com
ISIN: DE0005664809
WKN: 566480
Indices: TecDAX
Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
in Berlin, Düsseldorf, Hamburg, Hannover, München, Stuttgart
End of Announcement DGAP News-Service